Bayer AG
Johnson and Johnson
Novartis AG
AstraZeneca
Bristol-Myers Squibb
Boehringer Ingelheim International GmbH
Cytokinetics
Eli Lilly and Company
Jarvik Heart Inc.
Amgen Inc.
Otsuka Pharmaceutical Co. Ltd.
Tenax Therapeutics
Published | Pages | Publisher | Report code |
---|---|---|---|
Mar 2024 | 215 | Diligence Insights | ASDR-663031 |
Bayer AG
Johnson and Johnson
Novartis AG
AstraZeneca
Bristol-Myers Squibb
Boehringer Ingelheim International GmbH
Cytokinetics
Eli Lilly and Company
Jarvik Heart Inc.
Amgen Inc.
Otsuka Pharmaceutical Co. Ltd.
Tenax Therapeutics